Innovation Pharma Sees Drop in 2016

Innovation in Pharma Sees Drop in 2016

2016 proved to be less than stellar for pharmaceutical companies for a number of reasons, not least being a low point for marketing approval of new products (22 in 2016). While the industry continues to shift the focus of R&D efforts towards compounds that carve a niche in rare or specialty diseases...
Read More
Performance Metrics point view

Performance Metrics Point of View

A robust data strategy is essential to optimal commercial performance. However, most companies use dashboards that provide only a limited set of lagging indicators of performance with little information to guide diagnostics. A new approach to performance metrics can provide both predictive and diagn...
Read More